M.D., CEO & Co-founder, Medable
Biography
Dr. Michelle Longmire, M.D., founded Medable with the vision of making health technology as seamless and as integrated as the human body. With a background in image analysis and processing, she holds patents in machine learning as applied to medical diagnostics. Today, Dr. Longmire serves as the company’s CEO and leads the charge to digitize the clinical trial process and ultimately cut trial timelines in half.
AI and Data Sciences Showcase:
MEDABLE
Medable is on a mission to digitize the clinical trial process and cut trial timelines in half.
Digital Trials Radically Accelerate And Power A New Era Of Medicines And Therapies
A digital trial leverages technology throughout the clinical trial lifecycle to introduce new benefits compared to the stagnant and siloed processes developed 30 years ago.
- Learn how Digital Trials reduce time in development by 50%
- The impact of Digital Trials
- Examples of how trials are being digitized today in precision medicine
Session Abstract – PMWC 2020 Silicon Valley
Track 7 - January 22 9.00 A.M.-3.45 P.M.,Track 6 - January 23 11.15 A.M.-11.30 A.M.,Track 2 - January 24 11.15 A.M.-4.00 P.M.
The PMWC 2020 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
